Immuneering Corporation IMRX
4.27
(0.07)
(1.61%)
as of 25 Sep
- Market cap
- $280.8M
- P/E
- 0.0×
Follow IMRX
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | — | — |
+8 more quarters Free account |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
18.47 | 31.50 | 17.16 | 23.84 | |
Current Ratio |
19.47 | 32.45 | 17.50 | 24.00 | |
Net Debt/EBITDA |
7.73 | 10.07 | 12.58 | 14.96 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.96 | 1.37 | 0.85 | 0.80 | |
Capex/Depreciation |
0.07 | 0.36 | (7.33) | (0.04) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.03 | 0.03 | 0.03 | 0.03 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.26) | (0.29) | (0.22) | (0.30) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.26) | (0.29) | (0.23) | (0.30) | |
Cash per Share |
2.32 | 2.42 | 3.93 | 5.74 | |
Shareholders Equity per Share |
2.95 | 3.19 | 4.96 | 5.75 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
2.95 | 3.19 | 4.96 | 5.75 | |
Free Cash Flow |
(16.53) | (18.51) | (9.96) | (11.98) | |
Working Capital |
149.87 | 156.43 | 166.17 | 219.56 | |
Capital Expenditures |
(0.03) | (0.08) | (0.12) | (0.01) | |
Net Current Asset Value |
146.67 | 153.12 | 162.75 | 216.02 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
Average Payables |
2.89 | 1.38 | 1.75 | 1.77 | |
Average Assets |
121.06 | 132.75 | 142.35 | 154.81 | |
Average Common Equity |
109.84 | 124.18 | 129.94 | 142.85 |
Columns are period end dates